跨性别患者孤立与联合乳房增大术:多机构早期结局与风险因素分析
基于美国外科医师学会国家手术质量改进计划(ACS NSQIP)2008至2021年数据库,分析1699例女性跨性别个体接受乳房增大术(BAS)的30天结局。孤立BAS并发症率为2.8%,联合BAS为9.1%,且所有并发症均发生于联合泌尿生殖手术者。高龄和吸烟是联合BAS不良事件的危险因素,美国麻醉医师学会分级1级具有保护作用。
要点
- 孤立乳房增大术在女性跨性别个体中安全性良好,并发症率2.8%。
- 联合乳房增大术并发症率9.1%,所有并发症均见于联合泌尿生殖手术者。
- 高龄和吸烟是联合乳房增大术不良事件的危险因素。
核心结论
- 女性跨性别个体孤立乳房增大术安全性良好,联合手术尤其联合泌尿生殖手术风险更高。
- 识别吸烟和高龄等风险因素对患者选择和手术规划至关重要,这些发现可帮助完善患者资格并指导手术决策。
研究设计与样本
- 多机构回顾性数据库分析,使用美国外科医师学会国家手术质量改进计划(ACS NSQIP)2008至2021年数据。
- 共纳入1699例接受乳房增大术的女性跨性别个体,其中92%接受孤立乳房增大术,7.7%接受联合乳房增大术。
- 平均年龄36±12岁,平均体重指数27±6.6 kg/m2。
主要发现
- 孤立乳房增大术并发症率为2.8%,联合乳房增大术并发症率为9.1%。
- 所有并发症均发生于联合泌尿生殖手术的患者(n=85;14%),联合面部女性化手术(n=19)或软骨喉成形术(n=19)后未记录到不良事件。
- 在寻求联合乳房增大术的患者中,高龄(p=0.05)和尼古丁滥用(p=0.004)被确定为不良事件的危险因素。
- 美国麻醉医师学会分级1级具有保护作用(p=0.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The increasing demand for gender-affirming surgery (GAS) in transgender and gender-diverse healthcare highlights the importance of breast augmentation surgery (BAS) for transfeminine patients. Despite its significance, there is a lack of research on postoperative outcomes of BAS. METHODS: We analyzed the multi-institutional American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) (2008-2021) database to identify female transgender individuals (TGIs) who underwent BAS surgery, both isolated and combined with concurrent GAS procedures. We evaluated 30-day outcomes, including the incidence of mortality, reoperation, readmission as well as surgical and medical complication occurrence. RESULTS: Of 1699 female TGIs, 92% underwent isolated BAS and 7.7% underwent combined BAS. The mean age and body mass index (BMI) were 36 ± 12 years and 27 ± 6.6 kg/m2, respectively. Isolated BAS showed a 2.8% complication rate, while combined BAS had a higher rate with 9.1%. Specifically, all complications occurred in patients undergoing BAS with concurrent genitourinary surgery (n = 85; 14%), whereas no adverse events were recorded after combined BAS and facial feminization (n = 19) or chondrolaryngoplasty (n = 19). In patients seeking combined BAS, advanced age (p = 0.05) and nicotine abuse (p = 0.004) were identified as risk factors predisposing to adverse events, whereas American Society of Anesthesiology class 1 was found to be protective (p = 0.02). CONCLUSIONS: Isolated BAS in TGIs demonstrates a positive safety profile. Combined surgeries, particularly with genitourinary procedures, pose higher risks. Identifying risk factors such as smoking and advanced age is crucial for patient selection and surgical planning. These findings can aid in refining patient eligibility and inform surgical decision-making for BAS.
引用
- Knoedler S, Knoedler L, Geldner B, et al. Isolated and combined breast augmentation in transgender patients: Multi-institutional insights into early outcomes and risk factors. J Plast Reconstr Aesthet Surg. 2024. PMID: 38367411. doi:10.1016/j.bjps.2024.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。